Lecanemab (Leqembi)

Type: drug

Status: FDA Approved. Japan: Approved.

Developer: Eisai/Biogen

Breakthrough Summary

No summary available.

Mechanism of Action

Anti-amyloid antibody targeting protofibrils

Year: 2023+